A previous paper analysed the diffusion of transgenic crops in the agricultural sector and its relation with the development of biotechnology based industry. This work describes the ongoing legal dispute between the so-called Miami Cartel and the European Union and analyses the European legislative framework concerning commercialisation, labelling and traceability of GMOs. Finally, the systems for the protection of biotechnology intellectual property rights are discussed.